Elevated circulating levels of IL-6 in schizophrenia

Schizophrenia Research

Volumn 20, Issue 3, 1996, Pages 269-273

  Naudin, J ^a,d   Mege J L ^b   Azorin, J M ^a   Dassa, D ^c  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c TIMONE HOSPITAL   (France)

^d NONE   (France)

Author keywords

Autoimmunity; Cytokines; IL 6; Schizophrenia; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOLOGY; INFLAMMATION; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030570544     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(96)00014-X     Document Type: Article

References (37)

1. American Psychiatric Association (1987) Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn., revised. American Psychiatric Association, Washington, DC.
2. Campen, D.H., Horwitz, D.A., Quismorio, F.P. Jr, Ehresmann, G.R. and Martin, J.W. (1988) Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arth. Rheum. 11, 1358-1364.
3. Cavallo, M.G., Pozzilli, P. and Thorpe, R. (1994) Cytokines and autoimmunity. Clin. Exp. Immunol. 96, 1-7.
4. Condemi, J.J. (1987) The autoimmune diseases. JAMA 258, 2920-2929.
5. Davis, J., Janicak, P., Linden, R., Moloney, J. and Pavkovic, I. (1983) Neuroleptics and psychotic disorders. In: Coyle, J.T. and Enna, S.J. (eds) Neuroleptics: Neurochemical, Behavioral, and Clinical Perspectives. Raven Press, New York, pp. 15-64.
6. De Lisi, L.E., Goodman, S., Neckers, L.M. and Wyatt, R.J. (1982) Lymphocyte subpopulations in schizophrenic patients. Biol. Psychiatry 17, 1003-1007.
7. Dinarello, C.A. (1994) The biological properties of interleukin-1. Eur. Cytokine Netw. 5, 517-531.
8. Ganguli (1994) Mentioned in text but not in reference list
9. Ganguli, R. and Rabin, B.S. (1989) Increased serum interleukin-2 receptor concentration in schizophrenic and brain-damaged subjects (to the editor). Arch. Gen. Psychiatry 46, 292.
10. Ganguli et al. (1987) Mentioned in text but not in reference list.
11. Ganguli et al. (1989) Mentioned in text but not in reference list.
12. Ganguli, R., McAllister, C.G., Rabin, B.S., Solomon, W., Brar, J.S. and Rehn, T. (1991) Alterations in interleukin and in T lymphocyte subsets in a subgroup of schizophrenics. Biol. Psychiatry 29, 109A.
13. Ganguli, R., Yang, Z., Shurin, G., Chengappa, K.N.R., Brar, J.S., Gubbi, A.V. and Rabin, B.S. (1994) Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res. 51, 1-10.
14. Hyde, T.M. and Weinberger, D.R. (1990) The brain in schizophrenia. Sem. Neurol. 10, 276-286.
15. Katila, H., Appelberg, B., Hurme, M. and Rimon, R. (1994) Plasma levels of interleukin-1-β and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr. Res. 12, 29-34.
16. Kay, S.R., Opler, L.A. and Lindenmayer, J.P. (1989) The Positive and Negative Syndrome Scale (PANSS); rationale and standardization. Br. J. Psychiatry 155 (Suppl. 7), 59-65.
17. Kirch, D.G. (1993) Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr. Bull. 19(2), 355-370.
18. Knight, J.G., Knight, A. and Pert, C.B. (1987) Is schizophrenia a virally triggered antireceptor autoimmune disease?. In: Helmchen, H. and Henn, F.A. (eds) Biological Perspectives of Schizophrenia. Wiley, Chichester, pp. 107-127.
19. Licinio, J., Seibyl, J.P., Altemus, M., Charney, D.S. and Krystal, J.H. (1993) Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am. J. Psychiatry 150(9), 1408-1410.
20. Maes (1995) Mentioned in text but not in reference list.
21. Maes, M., Scharpé, S., Meltzer, H.Y., Bosmans, E., Suy, E., Calabrese, J., Cosyns, P. (1993) Relationships between interleukin-6 activity, acute-phase proteins and HPA-axis function in severe depression. Psychiatry Res., 49, 11-27.
22. Maes, M., Bosmans, E., Calabrese, J., Smith, R., Meltzer, H.Y. (1995) Interleukin-2 and Interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res., 29 (2), 141-152.
23. McAllister, S.A., Rapaport, M.H., Pickar, D., Podruchny, T.A., Christison, G., Alphs, L.D. and Paul, S.M. (1989) Increased numbers of CD5 + B lymphocytes in schizophrenic patients. Arch. Gen. Psychiatry 46, 890-894.
24. Murray and Lewis (1987) Mentioned in text but not in reference list.
25. Naudin, J., Dassa, D., Giudicelli, L., Mège, J.L. and Azorin, J.M. (1995) Schizophrénie, cytokines, et autoimmunité. Ann. Psychiatrie (in press).
26. Rapaport, M.H., McAllister, C.G., Pickar, D., Nelson, D.L. and Paul, S.M. (1989) Elevated levels of soluble interleukin-2 receptors in schizophrenia (to the editor). Arch. Gen. Psychiatry 46, 291-292.
27. Rapaport, M.H., Jeste, D.V., Lohr, J.B. and Stein, M. (1994) Soluble interleukin-2 receptors in psychiatric illness. Neuropsychopharmacology 10(35), 384S.
28. Rose, N.R. (1991) Characteristics of autoimmune disease. J. Invest. Dermatol. 96, 87S.
29. Shintani, F., Kanba, S., Maruo, N., Nakaki, T., Nibuya, M., Suzuki, E., Kinoshita, N. and Yagi, G. (1991) Serum interleukin-6 in schizophrenic patients. Life Sci. 49, 661-664.
30. Shwartz, R.S. and Datta, S.K. (1989) Autoimmunity and autoimmune diseases. In: Paul W. (ed.) Fundamental Immunology. Raven Press, New York, pp. 69-627.
31. Sirota, P., Fishman, P., Elizur, A. and Djaldetty, M. (1990) Lymphokine production in schizophrenic patients. Biol. Psychiatry 27, 118A.
32. Spitzer, R.L., Williams, J.B., Gibbon, M. and First, M.B. (1988) Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID). Biometrics Research Division, New York State Psychiatric Institute, New York.
33. Stefanis, C.N., Theodoropoulou-Vaidaki, S., Baxevanis, C.N., Spanakos, G., Papadopoulos, N.G., Economou, M. and Papamichael, M. (1994) Investigation of immune parameters in never medicated and chronically medicated schizophrenic patients. Neuropsychopharmacology 10(35), S-80-366.
34. Villemain, F., Chatenoud, L., Galinovski, A., Homo-Delarche, F., Ginestet, D., Loo, H., Zarifian, E. and Bach, J.F. (1989) Aberrant T cell-mediated immunity in untreated schizophrenic patients. Deficient interleukin-2 production. Am. J. Psychiatry 146, 609-616.
35. Waddington, J.L. (1993) Neurodynamics of abnormalities in cerebral metabolism and structure in schizophrenia. Schizophr. Bull. 19, 55-69.
36. Whicher, J. and Ingham, E. (1990) Cytokine measurements in body fluids. Eur. Cytokine Netw. 1, 239-243.
37. Yang, Z.W., Chengappa, K.N., Shurin, G., Rabin, B.S. and Ganguli, R. (1992) Low IL-2 production in schizophrenic patients is correlated with the clinical state and the presence of autoantibodies. Biol. Psychiatry 31, 207-A.